Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Advanced Biology|April 12, 2023
Partial Activation of PPAR-γ by Synthesized Quercetin Derivatives Modulates TGF-β1-Induced EMT in Lung Cancer CellsSangeeta Ballav, Amit Ranjan, Soumya BasuCarbohydrate Research|July 13, 2023
Extraction of dermatan sulfate using ionic liquid-assisted enzymatic digestion: An efficient approachAafiya Tarannum, Sangeeta Ballav, Jonnalagadda Raghava Rao, et al.Bioinformation|September 1, 2023
Comparative docking analysis of tyrosine kinase inhibitors with HER2 and HER4 receptorsPriyanka Sonar, Karimunnisa Shaikh, Sangeeta Ballav, et al.Cells|October 27, 2022
PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to CancerSangeeta Ballav, Bini Biswas, Vishal Kumar Sahu, et al.Journal of Molecular Modeling|August 21, 2020
Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule checkmate to cancer therapyKiran Bharat Lokhande, Sangeeta Ballav, Nachiket Thosar, et al.Journal of Biomolecular Structure & Dynamics|September 21, 2020
Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancerKiran Bharat Lokhande, Sangeeta Ballav, Rohit Singh Yadav, et al.Molecular Diversity|December 21, 2022
Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancerSangeeta Ballav, Kiran Bharat Lokhande, Rohit Singh Yadav, et al.Advanced Biology|April 5, 2023
Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer MetastasisSangeeta Ballav, Mrinalini Bhosale, Kiran Bharat Lokhande, et al.Pageof 1